PPT-Abstract highlights EASL NAFLD Summit 2019

About these slides These slides provide highlights of new data presented at the EASL NAFLD Summit 2019 Please feel free to use adapt and share these slides for your own personal use however please acknowledge EASL as the source. 1 DATA SHEET Summit x670V-48t HIGHLIGHTS The Summit X670V-48t switches are purpose-built top-of-rack switches designed to support emerging 10 Gigabit Ethernet and cloud data centers. Summit X670 Look for it Children and adolescents-. Too!. Dr. . Shrish. . Bhatnagar. Consultant Pediatric Gastroenterologist. VPIMS & . ELMCH,Lucknow. Dedication. JNMC. SGPGIMS. Dr S K BHATNAGAR. Hepatomegaly. non-alcoholic fatty liver disease. Dr. . Abdulwahhab. S. Abdullah. CABM, FICMS-G&H. Alcoholic liver . disease. Alcoholic liver . disease (ALD) is . one of the most common causes of . chronic liver disease worldwide.. Disease. . s_khalilzadeh. A Novel. Cardiometabolic Risk Factor for Type 2 Diabetes. NAFLD and T2DM. NAFLD is closely associated with features of the metabolic. syndrome and is regarded as the hepatic manifestation. New Advances for NAFLD/NASH NAFLD: A Spectrum of Disease Who Is at Risk for NAFLD and NASH? Prevalence of NAFLD in Europe Prevalence of NAFLD and NASH Predicted to Increase in Europe What Is the Burden of NAFLD in Europe? Moderator. Kris V. Kowdley, MD . Director . Liver Institute Northwest . Clinical Professor. Elson S. Floyd College of Medicine. Washington State University. Seattle, Washington . Overview of Discussion. William Alazawi MA(. Cantab. ) PhD MRCP. Senior Lecturer and Consultant in . Hepatology. Queen Mary, University of London. Does Liver Disease Matter?. Mortality in England & Wales. Liver-related mortality in under 65s. Non-Alcoholic Fatty Liver Disease (NAFLD)/ . Non-Alcoholic Steatohepatitis (NASH). Dr.. . Ranjitsinh. Devkar. Asst. Professor Department of Zoology, . The . M.S.University. of Baroda, Vadodara, India. Mohammad . Hassabi. (MD). Assistant Professor of Sports and Exercise Med. Dept.. Shahid. . Beheshti. University of Medical Sciences. Taleghani. Medical Center. Physical activity. Exercise. . Sports. not an equal opportunity: implications for women’s health. Alina M. Allen MD. , Patrick S. Kamath MD, Joseph J. Larson, . Kymberly D. Watt MD, . Sharonne. N. Hayes MD, Terry M. . Therneau. PhD. Mayo Clinic, Rochester, MN. April 10. –14. , 2019. Vienna, Austria. Disclaimer. These non-promotional slides are intended to be used as educational material only in response to an unsolicited question or request. The double-dagger (. Rohit . Pai. MD, FRCPC. Gastroenterology and Hepatology. Island Health and Pacific Digestive Health. Clinical Assistant Professor, UBC. Liver Care Clinic, Royal . Jubillee. Hospital. Disclosures. Research: Intercept. Diabetes. Hypertension. HDL < 1 . mmol. /L . Triglycerides > 1.7 . mmol. /L. Suspicion of NAFLD ?. Remember normal LFT’s do not rule out liver disease Exclude significant alcohol misuse (intermediate or high risk group in the alcohol related liver disease pathway) before diagnosing NAFLD via this pathway. Carolyn Yanavich, . Antônio Pacheco, Sandra . W Cardoso, Estevão Portela, Ursula . B Chaves, Ricardo Santos, . Michelle Morata, . Valdilea . G Veloso, Beatriz . Grinsztejn, . Hugo Perazzo. National Institute of .